These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 17658412)

  • 41. 2006 Bethesda International Consensus Conference on Flow Cytometric Immunophenotyping of Hematolymphoid Neoplasia.
    Stetler-Stevenson M; Davis B; Wood B; Braylan R
    Cytometry B Clin Cytom; 2007; 72 Suppl 1():S3. PubMed ID: 17630651
    [No Abstract]   [Full Text] [Related]  

  • 42. Harmonemia: a universal strategy for flow cytometry immunophenotyping-A European LeukemiaNet WP10 study.
    Lacombe F; Bernal E; Bloxham D; Couzens S; Porta MG; Johansson U; Kern W; Macey M; Matthes T; Morilla R; Paiva A; Palacio C; Preijers F; Ratei R; Siitonen S; Allou K; Porwit A; Béné MC
    Leukemia; 2016 Aug; 30(8):1769-72. PubMed ID: 26922887
    [No Abstract]   [Full Text] [Related]  

  • 43. [The immunology laboratory in malignant blood diseases].
    López Berges MC; Vidriales B; Ocqueteau M; Orfao A
    Sangre (Barc); 1996 Aug; 41(4):281-8. PubMed ID: 8984669
    [No Abstract]   [Full Text] [Related]  

  • 44. Immunophenotyping of chicken peripheral blood lymphocyte subpopulations: individual variability and repeatability.
    Fair JM; Taylor-McCabe KJ; Shou Y; Marrone BL
    Vet Immunol Immunopathol; 2008 Oct; 125(3-4):268-73. PubMed ID: 18602700
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Modulated multiparametric phosphoflow cytometry in hematological malignancies: technology and clinical applications.
    Covey TM; Cesano A
    Best Pract Res Clin Haematol; 2010 Sep; 23(3):319-31. PubMed ID: 21112033
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Towards standardization in immunophenotyping hematological malignancies. How can we improve the reproducibility and comparability of flow cytometric results? Working Group on Leukemia Immunophenotyping.
    Lanza F
    Eur J Histochem; 1996; 40 Suppl 1():7-14. PubMed ID: 8839695
    [No Abstract]   [Full Text] [Related]  

  • 47. Flow cytometry in hematological nonmalignant disorders.
    Béné MC; Le Bris Y; Robillard N; Wuillème S; Fouassier M; Eveillard M
    Int J Lab Hematol; 2016 Feb; 38(1):5-16. PubMed ID: 26542092
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Flow cytometry for hematopoietic cells.
    Krause DS; Delelys ME; Preffer FI
    Methods Mol Biol; 2014; 1109():23-46. PubMed ID: 24473776
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A national policentric study for the definition of a reference range for normal values of peripheral blood lymphocyte subsets in healthy adults.
    Santagostino A; Garbaccio G; Pagliaro P; Girotto M; Camisasca G; Bolis V; Pistorio A
    Eur J Histochem; 1997; 41 Suppl 2():205-6. PubMed ID: 9859850
    [No Abstract]   [Full Text] [Related]  

  • 50. Validation and quality control of immunophenotyping in clinical flow cytometry.
    Owens MA; Vall HG; Hurley AA; Wormsley SB
    J Immunol Methods; 2000 Sep; 243(1-2):33-50. PubMed ID: 10986405
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Isotype controls--time to let go?
    O'Gorman MR; Thomas J
    Cytometry; 1999 Apr; 38(2):78-80. PubMed ID: 10323221
    [No Abstract]   [Full Text] [Related]  

  • 52. International consensus recommendations on the flow cytometric immunophenotypic analysis of hematolymphoid neoplasia.
    Wilson WH
    Cytometry B Clin Cytom; 2007; 72 Suppl 1():S2. PubMed ID: 17803186
    [No Abstract]   [Full Text] [Related]  

  • 53. Recent advancements of flow cytometry: new applications in hematology and oncology.
    Woo J; Baumann A; Arguello V
    Expert Rev Mol Diagn; 2014 Jan; 14(1):67-81. PubMed ID: 24308362
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Radiotherapy-induced changes of peripheral blood lymphocyte subpopulations in cervical cancer patients: relationship to clinical response.
    Eric A; Juranic Z; Tisma N; Plesinac V; Borojevic N; Jovanovic D; Milovanovic Z; Gavrilovic D; Ilic B
    J BUON; 2009; 14(1):79-83. PubMed ID: 19373951
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Developments in the immunophenotypic analysis of haematological malignancies.
    Heel K; Tabone T; Röhrig KJ; Maslen PG; Meehan K; Grimwade LF; Erber WN
    Blood Rev; 2013 Jul; 27(4):193-207. PubMed ID: 23845589
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Immunophenotyping in modern leukemia diagnosis].
    Kern W; Diem H; Haferlach T
    Dtsch Med Wochenschr; 2005 Feb; 130(5):215-9. PubMed ID: 15678390
    [No Abstract]   [Full Text] [Related]  

  • 57. Quality control in phenotypic analysis by flow cytometry.
    Hurley AA
    Curr Protoc Cytom; 2001 May; Chapter 6():Unit 6.1. PubMed ID: 18770714
    [TBL] [Abstract][Full Text] [Related]  

  • 58. EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes.
    van Dongen JJ; Lhermitte L; Böttcher S; Almeida J; van der Velden VH; Flores-Montero J; Rawstron A; Asnafi V; Lécrevisse Q; Lucio P; Mejstrikova E; Szczepański T; Kalina T; de Tute R; Brüggemann M; Sedek L; Cullen M; Langerak AW; Mendonça A; Macintyre E; Martin-Ayuso M; Hrusak O; Vidriales MB; Orfao A;
    Leukemia; 2012 Sep; 26(9):1908-75. PubMed ID: 22552007
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Improving preanalytic processes using the principles of lean production (Toyota Production System).
    Persoon TJ; Zaleski S; Frerichs J
    Am J Clin Pathol; 2006 Jan; 125(1):16-25. PubMed ID: 16482987
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immunophenotyping of hematopoietic neoplasms.
    Chu PG; Chang KL; Arber DA; Weiss LM
    Semin Diagn Pathol; 2000 Aug; 17(3):236-56. PubMed ID: 10968709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.